Vivos Therapeutics (VVOS) Revenue (2020 - 2026)
Vivos Therapeutics (VVOS) reported Revenue of $5.1 million for Q1 2026, up 70.46% year-over-year from $3.0 million in Q1 2025, and up 34.44% quarter-over-quarter from $3.8 million in Q4 2025.
Vivos Therapeutics (VVOS) Revenue (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Revenue data on file, last reported at $5.1 million in Q1 2026.
- Revenue for Q1 2026 came in at $5.1 million, up 70.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.6 million (up 33.77% YoY), and the FY2025 annual result was $17.4 million, up 16.05% from the prior year.
- Revenue climbed to $5.1 million in Q1 2026 per VVOS's latest filing, from $3.8 million in the prior quarter.
- Over five years, Revenue peaked at $6.8 million in Q3 2025 and troughed at $3.0 million in Q1 2025.
- A 5-year average of $4.0 million and a median of $3.8 million in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2023 and 2025: Revenue dropped 22.26% in 2023, then surged 75.73% in 2025.
- A 5-year view of Revenue shows it stood at $4.0 million in 2022, then fell by 17.77% to $3.2 million in 2023, then increased by 13.85% to $3.7 million in 2024, then gained by 3.41% to $3.8 million in 2025, then soared by 34.44% to $5.1 million in 2026.
- Business Quant data shows VVOS's Revenue at $5.1 million in Q1 2026, $3.8 million in Q4 2025, and $6.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 11.16 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.02 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 9.02 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 5.20 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.65 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.57 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.19 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.59 Bn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | 5.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.14 Mn |
| Dec 31, 2025 | 3.82 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 3.86 Mn |
| Jun 30, 2024 | 4.05 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Dec 31, 2023 | 3.25 Mn |
| Sep 30, 2023 | 3.30 Mn |
| Jun 30, 2023 | 3.40 Mn |
| Mar 31, 2023 | 3.86 Mn |
| Dec 31, 2022 | 3.95 Mn |
| Sep 30, 2022 | 4.25 Mn |
| Jun 30, 2022 | 4.18 Mn |
| Mar 31, 2022 | 3.64 Mn |
| Dec 31, 2021 | 4.39 Mn |
| Sep 30, 2021 | 4.55 Mn |
| Jun 30, 2021 | 4.50 Mn |